AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the London-listed group looks to build its presence in cutting-edge cancer treatments.
A new survey says consumers find e-commerce sites often fail to meet expectations. Experts say that’s because shoppers have become accustomed to how...